PIPERACILLIN AND BETA-LACTAMASE INHIBITOR , NEGABAN 2 g, poudre pour solution injectable/pour perfusion, MEROPENEM ARROW 1 g, poudre pour solution injectable / pour perfusion
APHP211034
Phase 3 small_molecule active
Quick answer
PIPERACILLIN AND BETA-LACTAMASE INHIBITOR , NEGABAN 2 g, poudre pour solution injectable/pour perfusion, MEROPENEM ARROW 1 g, poudre pour solution injectable / pour perfusion for patients hospitalized in ICU with ESBL-producing Enterobacteriaceae severe infection is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- patients hospitalized in ICU with ESBL-producing Enterobacteriaceae severe infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active